Leerink Swann analysts were out today with favorable reports on pharmaceutical giant Gilead Sciences, Inc.(NASDAQ:GILD) and cannabis-based drug maker GW Pharmaceuticals PLC (NASDAQ:GWPH).
Gilead Sciences, Inc. Leerink Swann analyst Geoff Porges reiterated an Outperform rating on shares of Gilead Sciences, Inc.
Leerink Swann’s healthcare analysts came out today with favorable reports on pharmaceutical giants Gilead Sciences, Inc. (NASDAQ:GILD) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ).
Shares of biotech companies Oncomed Pharmaceuticals Inc (NASDAQ:OMED) and OvaScience Inc (NASDAQ:OVAS) fell sharply today following clinical trial setback and analyst downgrade, respectively. Let’s take a look and see …
The biotech sector has had a cruel start to the year. The Nasdaq Biotechnology Index (IBB) is down 19% so far in 2016, …
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies – fell nearly 4% this week amid a renewed selloff in …
In a research report issued Tuesday, Leerink Swann analyst Paul Matteis initiated coverage on shares of Cempra Inc (NASDAQ:CEMP), with a Market Perform …
Leerink Swann analyst Howard Liang came out with some of his opinions on Celgene Corporation (NASDAQ:CELG) following the 13th International Conference on Malignant Lymphoma (ICML) …
Leerink Swann analyst Jason Gerberry came out with some commentary on Heron Therapeutics Inc (NASDAQ:HRTX) following the initiation of a Phase 2 clinical trial of …
